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Background: GPs currently deal with COPD. The aim of this study was to review COPD management, data
collection in medical records, and adherence to GOLD guidelines of 12 GPs from rural areas of Northern Italy and to
assess changes after an educational program (EP).
Methods: From 2004 to 2008 medical records of patients, defined as COPD by GPs, were analyzed. Data collection
in terms of tests prescription, Forced Expiratory Volume at first second (FEV1), smoking habits and actual drug
treatment were reviewed at baseline and 1 year after EP.
Results: 437 patients were defined as COPD. GPs prescribed more chest X-rays than spirometry (99% vs. 74%,
p<0.001), FEV1 was registered only in 50% of the population. GPs prescribed “correct” or “doubtful” (not related to
FEV1) therapy in 38% and 56% of patients, respectively. Only smoking habit registration increased significantly
(p<0.05) after EP.
Conclusions: Adherence to COPD Guidelines is suboptimal and data collection is poor. The EP did not change
significantly GPs’ practice: i) COPD diagnosis is largely clinical, ii) usage of spirometry is poor, GPs prescribe more
chest X-rays iii) a small proportion of patients receive respiratory therapy, iv) therapy is often incorrect or not related
to FEV1, v) correct clinical practice is influenced by the number of COPD patients and number of dedicated visits.
Keywords: Continuity of care, Educational, General practitioner, ManagementBackground
The prevalence of Chronic Obstructive Pulmonary Disease
(COPD) is increasing worldwide [1]. In Italy, the majority
of patients affected by COPD or presenting symptoms of
obstructive airways disease refer to General Practitioners
(GPs) for treatment. There are concerns of under-diagnosis
and under-treatment of COPD in primary care setting.
Symptoms indicating COPD should be interpreted properly
by GPs and a definitive diagnosis should be confirmed
by pulmonary function tests according to recommended
guidelines [2-4]. Under-diagnosis has been reported due
to under-presentation of symptoms by patients or lack
of diagnosis by physician but also over-diagnosis might
occur [2,5,6].* Correspondence: michele.vitacca@fsm.it
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reproduction in any medium, provided the orIn previous studies, it has been reported that patients
with suspicion of COPD never performed a spirometry
nor visited a respiratory specialist [2,6].
GPs examine a large number of patients with different
and multiple conditions and in this complex setting they
can have difficulties in adhering to every disease-specific
guidelines [7].
People with unrecognized COPD may miss the oppor-
tunity to improve their health status because of lack of
prescription of functional tests [8].
It has been reported that GPs continue to be unaware
of COPD guidelines and other information related to
COPD, suggesting the need for continuing educational
programs [8].
A recent paper [9] has showed that in 139 GPs following
454 patients, guideline adherence does not seem to impact
symptom prevalence, exacerbation rate or lung function
decline after one year of follow up.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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istered involving 400 Italian GPs, revealed that treatment
was usually prescribed without performing pulmonary
function tests and/or without taking into account the se-
verity of airway obstruction [10]. More recently another
Italian study [11] showed a poor relationship between the
recommendations of the GOLD international guidelines
and current clinical practice performed by pulmonologists.
When COPD has been diagnosed, a plan for clinical
management is necessary because planned care can im-
prove quality of life and reduce the economic burden re-
lated to hospital admissions and emergency visits [12].
To this end, we designed the current study with the
aims of:
1. reviewing data collected by GPs in the medical
records of their COPD patients
2. assessing the extent of under-treatment and
adherence to GOLD guidelines for diagnostic and
therapeutic procedures in a rural area
3. investigating whether management can be affected
by an educational program.Methods
Setting
The survey was carried out between 2004 and 2009 in
the GPs’ office in a mountains/rural area with iron and
steel industries of the Lombardy region (Val Trompia -
Brescia) covering an area of 380 square kilometers [2],
with 114,081 inhabitants.
In this area, a hospital for acute patients with emergency
room is available and 70 GPs are employed in public home
health services. Since 2006, a new specialized rehabilitative
hospital (Fondazione Salvatore Maugeri, IRCCS for chronic
diseases) has been offered to the territory.
Spirometry is easily available at both the above men-
tioned hospitals and other 2 pulmonary pathophysiology
services at Spedali Civili in Brescia. Gp’s Prescription is
required. The distance from any GP’s office to these hos-
pitals is no more than 20 Km.Clinical data
Clinical information was retrieved by the Health Search
Database (HSD) used by participating GPs. Since 2005, all
GPs of this area had HSD, were well trained to use this
standardized system and registered clinical data in the pa-
tient’s electronic files. The HSD contains information on
patients’ demographics, medical records and drug history
including records of preventive measures. All diagnoses
were coded according to the 9th revision of the Inter-
national Classification of Disease (ICD-9) [13].
All data were extracted with a specific query from a
dedicated software named Millewin: the query was sentto all GPs and the results were reversed in an Excel file
to be analyzed.
Information on drugs was coded according to the lat-
est version of Anatomical Therapeutic Chemical (ATC)
classification system [14]. No data were available on
symptoms.
The study was organized in two parts: 1. retrospective
collection of basal data before an educational program
(pre-education); 2. re-evaluation of clinical data 1-year
after an educational plan on COPD knowledge and treat-
ment. At the time of the study no specific COPD guideline
dedicated to GPs was available.
Data collection
Retrospective analysis (Pre-educational program)
The data analysis was conducted at Fondazione Salvatore
Maugeri by a respiratory specialist.
All medical records of patients with diagnosis of COPD,
as defined by GPs in the period 2004–2008, were retro-
spectively evaluated and reviewed at the end of October
2008.
The following data were considered for analysis: 1.
spirometry and chest X–rays prescribed. 2. Forced Ex-
piratory Volume at first second (FEV1) value and smo-
king habits registered in the previous 5 years (from 2004
to end 2008). 3. drug treatment regarding the last year
of the abovementioned period. GPs’ prescription for
drug treatment was evaluated in accordance with GOLD
guidelines [1].
“Correct” prescription was defined as: a) No regular
treatment at stage I b) Regular treatment with long-
acting anti-muscarinic agents (LAMA) or long-acting
bronchodilator agents (LABA) (or both) in symptomatic
patients at stage II c) Regular treatment with inhaled
corticosteroids (ICS) on top of long-acting bronchodila-
tors, in general as fixed-dose combinations in patients at
stages III and IV.
“Incorrect” prescription was defined as: a) regular
treatment with LABA or LAMA alone at stages III, IV;
b) only SABA at stage II and III; c) LABA or LAMA or
ICS at stage I; d) ICS at stage II e) ICS on top of long-
acting bronchodilators at stages I and II; f ) no drugs
were prescribed; g) theophylline was prescribed alone.
When GPs prescribed therapy was without registration
of FEV1, the therapy was considered “doubtful”.
Continuous educational program
The educational program was performed in January
2009. It was organized on 3 major points:
1) face to face lectures on disease knowledge and
treatment: GPs attended two series of learning
sessions lasting 3 hours performed by respiratory
specialists from FSM. These sessions focused on
Table 1 Clinical data of the patients’ population (437)
registered in the GPs’ HDS database
Pre-educational program
2004-2008
CHEST XRs
# of pts (%) 433 (99)
# of exams/pt/year±SD 0.5 ± 0.6
SPIROMETRY
# of pts (%) 325 (74.3)°
# of exams/pt/year±SD 0.3 ± 0.4
FEV1 registered
# of pts (%) 215 (49.2)
% of patients/all pts with spirometry 66.1
FEV1 % prd 81.0 ± 21.0
GOLD I % 43
GOLD II % 48
GOLD III % 8
GOLD IV % 1
SMOKING REGISTRATION
# of pts (%) 323 (73.9)
# current smokers (%) 32 (7.4)
VISITS TO GP per pt, per year
Mean±SD 17.9 ± 13.4
Legend: P = 0.000 Spirometry vs Chest XRs.
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information was accompanied by a written teaching
manual adapted from the “Living Well with COPD”
program [15].
2) skills implementation strategy: GPs visited our
Hospital and attended the pathophysiology
laboratory for a couple of hours to implement their
knowledge, utility and modality of the spirometry
test.
3) second medical opinion: respiratory specialists
offered to GPs (by telephone) their clinical
consultation when needed.
Analysis of data after the educational program
In January 2010, one year after the educational program,
the clinical parameters collected before the educational
program, were re-evaluated.
Statistical analysis
Data were reported as number, percentage or mean ±
SD. Paired Student t-test and χ-square were used for
comparison as appropriate. P-values< 0.05 was consid-
ered statistically significant.
Results
12 GPs participated to the study, 2 were female, the
mean age was 52 years (range 45–56).
Data Collection and Retrospective Analysis
(Pre-Educational Program)
At the end of 2008, medical records of 18,024 patients
were reviewed and 437 patients were defined affected with
COPD (2.42%) by GPs. The mean age was 69.8±12.9 years,
151 were females (35%).
Table 1 shows the basal data of COPD patients re-
trieved from HDS within a 5 years period (2004–2008).
GPs prescribed more chest X-rays than spirometry (99%
vs. 74%, p< 0.001) and FEV1 was registered only in 215
patients (49.2%). It was only in these patients that the
severity of COPD, according to GOLD guidelines, could
be classified. 91% of COPD patients were GOLD I or II.
Smoking registration was available for 323 patients
(73.9%). Only 188 out of 437 (43%) patients, defined as
COPD, received some respiratory therapy. Differences in
data collection were observed among GPs: spirometry
has been performed from 14% to 76% of COPD patients
and FEV1 has been registered from 0% to 76%.
Continuous educational program
All 12 GPs attended the educational sessions and Hospital
visits. During 1-year activity, 7 out of 12 GPs required a
second opinion performing 12 calls to the respiratory
specialists.Analysis of data after educational program
109 patients (25%) were lost to follow- up because of death,
change of GPs or residence; baseline data of these patients
did not differ from those still in the study.
328 patients (75% of the baseline group) remained in
the study. The mean age was 69 ± 12.2 years, 107 were
female.
Table 2 shows clinical data registered by GPs in the
328 patients present in the HDS before and after the
educational program.
The number of Chest X-rays performed was signifi-
cantly higher than that of spirometry (p< 0.001) at both
time points. After the educational program, prescriptions
of Chest X-rays and spirometry did not change signifi-
cantly. 39 out of 55 patients (71%) who performed
spirometry during 2009 had not performed it in the pre-
vious year and only 15 out of 55 patients (27%) had
never performed it either in the previous year or in the
last five years. In 33% of spirometry, FEV1 was not regis-
tered. Smoking habits registration increased significantly
from 78 to 91% (p< 0.05). Also after the EP, differences
were observed among GPs. Only 8 GPs improved spi-
rometry prescription (improvement was defined both for
the total number of prescriptions and the presence of at
least 1 new prescription) and 5 improved FEV1 registra-
tion (from 2%to 20%): a correlation was found between
Table 2 Clinical data registered in the GP’s HDS database
for 328 patients available before and after the
educational program
2008 2009
CHEST XRs
# of pts (%) 101 (31) 93 (28)
# of exams/pt±SD 0.44 ± 0.82 0.37 ± 0.69
SPIROMETRY
# of pts (%) 64 (19)° 55 (17)°
# of exams/pt±SD 0.23 ± 0.53 0.19 ± 0.46
FEV1 registered
# of pts 49 47
% of patients/all 328 pts 15 14
% of patients/all pts with spirometry 76.6 85.5
FEV1 % prd 77.0 ± 38.0 79.0 ± 26.0
GOLD I % 41 45
GOLD II % 49 38
GOLD III % 8.2 15
GOLD IV % 2 2
SMOKING REGISTRATION
# of pts (%) 255 (78) 298 (91)*
current smokers (%) 34.1 32.5
VISITS TO GP per pt, per year (mean±SD) 17.9 ± 12.1 9.15 ± 13.2
* p = 0.000 Educational program vs pre-educational program; and ° p =0.000.
Spirometry vs Chest XRs.
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ber of FEV1 registered (p = 0.023).
Table 3 shows drugs prescription data in 328 patients
present in the HDS before and after the educational
program.
In 2008, only one third of these patients received re-
spiratory therapy. GPs prescribed “correct”, “incorrect”
or “doubtful” therapy in 38%, 6% and 56% of cases re-
spectively. 75 patients (23% of the whole population)Table 3 Data related to actual drug treatment for 328
patients available before and after the educational
program
2008 2009
# of pts on regular treatment (%) 127 (38.7) 109 (33.2)
# of pts on correct therapy (%) 48 (14.6) 48 (14.6)
% of patients/pts receiving therapy 37.8 44
# of pts on incorrect therapy 8 (2.4) 9 (2.7)
% of patients/pts receiving therapy 6.3 8.2
# of pts on doubtful treatment 71 (21.6) 52 (15.8)
% of patients/pts receiving therapy 55.9 47.4
# of pts on oxygen therapy 2 2
Correct, according to GOLD guidelines; incorrect=, irrespective of GOLD
guidelines; doubtful=, not related to FEV1 severity registration.had the FEV1value reported, but received no therapy des-
pite the evidence of airway obstruction. No significant
changes in the therapeutic approaches were observed after
the educational program.
The most frequent mistake was the overuse of steroids
and theophylline in mild obstruction and the prescrip-
tion of only short acting β2 agonists in GOLD II and III.
Patients receiving the correct therapy in 2008 (Figure 1,
Top panel left) and patients who performed at least one
spirometry during the previous five years (Figure 1, Bot-
tom panel left), underwent a significantly higher number
of GPs examinations compared to patients with incorrect
therapy (Figure 1, Top panel right, p=0.025) and without
spirometry (p<0.03) (Figure 1 Bottom panel right, p=0.029).
Similar data were found after the educational program.
Discussion
This study shows that adherence to the international
COPD Guidelines by Italian GPs is suboptimal and data
collection in medical records is poor and incomplete.
Moreover, the educational program had a very limited
impact on GPs’ clinical practice. Indeed, in primary care
setting: i) the diagnosis of COPD is still largely clinical,
ii) the usage of spirometry is poor with GP tending to
perform more chest X-rays than pulmonary function
tests, iii) a small proportion of patients receive respira-
tory therapy, iv) the prescribed therapy is often incorrect
or not related to FEV1, v) correct clinical practice is
influenced by the number of COPD patients followed
and the number of dedicated visits.
In this study the prevalence of COPD in this area was
around 2.4%, which is a little less than that estimated in
the general population (5%) [13,14,16] but similar to the
Italian data reported by Cazzola et al. [10]. The under-
diagnosis of COPD in primary care medicine is probable
and has already been described in literature [2]. Despite
the educational sessions, in 2009 the number of patients
who performed a spirometry was similar to that in 2008,
55 (17%) vs. 64 (19%), respectively, and only 15 patients
performed a spirometry for the first time in 2009. The
reason of this lack of improvement in spirometry testing
is not clear. It could be due to the workload of the GPs
or to the necessity of cost saving. On the other hand,
spirometry could be perceived by GPs as not useful for
determining starting therapy, since treatment is based
on symptoms. The latter explanation is supported by the
relation found between the number of visits to the GPs
and the prescription of spirometry and “correct” therapy:
higher the number of GP contacts, higher the probability
for the patient to be submitted to spirometry and correct
therapy.
The number of patients who had FEV1 value registered
was even lower before the educational sessions. After
these latter ones, the number of registered FEV1 in
Figure 1 Number of visits to GPs in patients with correct or
incorrect therapy at the end of 2008 (TOP) and in patients with
or without spirometry prescription (BOTTOM) during 2004–2008.
* p=0.025 °p=0.029.
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improvement in the prescription of pulmonary function
tests, for GPs the importance to classify severity of
COPD was clear. It is noteworthy that the patients with
FEV1 registered had mostly mild to moderate disease,
thus it is possible that GPs refer more severe patients to
specialists without reporting the results of tests and
visits. This could explain the large number of patients
under therapy without registration of FEV1.
On the other hand we found that GPs with higher
number of COPD patients tend to register FEV1 more
frequently. This brings out the importance of experience
and correct case funding in the management of a par-
ticular disease.
Smoking habits is a major risk factor for COPD: GPs
are aware that smoking habits must be registered. How-
ever, in 22.3% of patients this data was not registered.
Smoking registration increased significantly to approxi-
mately 90% after the educational sessions, but the num-
ber of current smokers (34.1%) decreased only slightly
after the educational program (32.5%).
The data about treatment were surprising. Prior to the
educational program the percentage of patients receiving
therapy for COPD, either “correct” or “incorrect”, wasvery small (38.7%). This data would not have been
underestimated because therapy is routinely prescribed
by GPs even if under specialist’s advice. Of these patients
under treatment, more than 50% received therapy prob-
ably not related to FEV1. It is possible that the GPs have
looked at spirometry without reporting the data or that
the therapy have been prescribed by a specialist and only
reported by the GP. In any case, it is not possible to
state if the therapy taken by these patients was “correct”.
Among 56 patients who had registration of FEV1 and re-
ceived therapy, 48 received drugs appropriate for the se-
verity of obstruction and eight received an “incorrect”
therapy. The fact that the most frequent mistake was the
abuse of steroids, theophylline or short acting β2 ago-
nists may be explained with the hypothesis that GPs
often start therapy after a relapse and subsequently
maintain the same therapy without further investiga-
tions. The large number of untreated COPD cases could
possibly reflect incorrect diagnoses.
After the educational sessions, the number of patients
receiving therapy decreased. In particular, the reduction
was among the group of patients without FEV1. This
made us believe that the reason could be a cessation of
therapy by the GPs pending a definitive diagnosis. In any
case, it is noteworthy that patients (less that 15%) with
an appropriate therapy were very few indeed.
Table 2 shows that the mean number of visits/patient
was 17.9 in 2008 and 9.15 in 2009. In our opinion this
reduction could be a positive sign because patients felt
better and had less exacerbations and did not need to
visit the GP. This hypothesis would agree with a recent
study [17] reporting that respiratory medications prescribed
in COPD complied poorly with the GOLD pharmacologic
treatment guidelines, but were correlated with the number
of prior respiratory healthcare visits.
In the management of COPD, a discrepancy between
prescribed therapy and guidelines has been observed in
several previous studies [9-11,18,19].
Our results are similar to that observed both in Italy
and worldwide [6,9-11]. A recent Italian study [11]
conducted by pulmonologists showed a poor relation-
ship between the recommendations of the GOLD inter-
national guidelines and current clinical practice: out of
44,094 patients recruited, a total of 302 (7.4%), of whom
263 at stages I and II and 39 at stages III and IV, did not
receive any regular pharmacological treatment for
COPD; the remaining 23,792 (92.6%) received at least 1
drug on a regular basis.
GPs seem to pay more attention to the treatment of
symptoms than to the diagnosis of a chronic condition.
Even though symptoms are important to suspect COPD
and follow its evolution, they are not sufficient to make
a diagnosis of COPD. GOLD guidelines [1] indicate spir-
ometry as the only evaluation to confirm or exclude
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nostic criteria of COPD. Moreover, post-bronchodilator
FEV1 is needed to define the severity of the disease and
thus to prescribe the “correct” therapy [1].
In a Swiss study [9] an inappropriate treatment for their
stage of disease was found in 44% of all COPD patients
after one year of follow up compared to 47% at baseline
when treated by GPs. Different results were reported by a
Danish study [19] which shows that substantial improve-
ments can be achieved by focused education of GPs. A
Spanish study conducted by Soler et al. [20] showed im-
provement in COPD diagnosis and management after a
training program for GPs with an additional improvement
when GPs were given a spirometric device. Other publica-
tions have supported the feasibility and use of spirometry
testing by GPs [21,22].Implications for future research or clinical practice
We believe that more research must be done to improve
COPD management in primary care. In addition, more
structured and continuous educational program with
practical training are necessary to address knowledge
gaps and mistakes in daily practice. Technology such as
personal electronic card and/or telemedicine can help to
facilitate dialogue between GPs and specialists [23] and
could offer new useful tools to improve the management
of COPD by GPs as recently shown by Bonavia et al.
[24]. GPs need support in COPD management; correct
case funding and adequate numbers of dedicated visits
are paramount to improve clinical practice.Limitations of the study
The main limitation of this study is that the standard for
drug prescriptions was based on the GOLD guidelines
[1]: these guidelines may not be universally accepted due
to the emerging necessity to individualize drug therapy
according to more sophisticated and holistic parameters
rather than the pure FEV1 value.
A second limitation is the absence of symptoms registra-
tion in the database used, thus the only reference to evalu-
ate treatment decisions was FEV1. However, a recent paper
[9] has showed in 139 GPs that guideline adherence does
not seem to impact symptom prevalence, exacerbation rate
or lung function decline after one year of follow up.
Another important limitation is that this study is partly
designed as retrospective. A retrospective analysis of a
Health Search Database for GPs is limited by the fact that
the physicians using the database were not trained to spe-
cifically register the variables needed for the present study.
A negative result of the training course could be caused
by under-registration of data by the physicians, in particu-
lar for possible visits performed by pulmonologists. On
the other hand, this fact may be a strength of the studybecause GPs were not obliged to a specific protocol and
the present data are the real life mirror of their habits.
Conclusions
In conclusion, since the adherence to the COPD guide-
lines by Italian GPs is suboptimal and educational pro-
gram on respiratory medicine had a very limited impact
in the clinical practice, more integrated and synergistic
hospital-GP strategies are recommended for improving
management of chronic respiratory diseases.
Abbreviations
ATC: Anatomical Therapeutic Chemical; COPD: Chronic Obstructive
Pulmonary Disease; EP: Educational Program; FEV1: Forced Expiratory Volume
at first second; GPs: General Practitioners; HSD: Health Search Database; ICD-
9: International Classification of Disease; ICS: Inhaled Corticosteroids;
LABA: Long-Acting Bronchodilators Agents; LAMA: Long-Acting Anti-
Muscarinic Agents; SIMG: Italian College of General Practitioners.
Competing interests
The Authors have no conflicts of interest to disclose.
Body living ethics approval
Fondazione Salvatore Maugeri, IRCCS (Lumezzane, Brescia).
Acknowledgements
The Authors are indebted with Dr Laura Comini for the technical and
scientific assistance in editing the manuscript and Alessandro Bettini for the
English editing assistance.
They also thank the GPs: Eliana Belleri, Giuseppe Beltrami, Francesco Benfatti,
Elena Casilli, Giovanni Gatta, Claudio Pagani, Fabio Pederzani, Roberto
Richiedei, Giorgio Rossigni, Massimo Sala and Alessandro Tabaglio, belonging
the General Practitioner Distretto 04 ASL 02 Brescia, for collecting data.
Received: 12 September 2012 Accepted: 28 January 2013
Published: 19 March 2013
References
1. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global
strategy for the diagnosis, management, and prevention of chronic obstructive
pulmonary disease. 2006.
2. Albers M, Schermer T, Molema J, Kloek C, Akkermans R, Heijdra Y, van Weel
C: Do family physicians’ records fit guideline diagnosed COPD?
Fam Pract 2009, 26:81–7.
3. van der Molen T, Østrem A, Stallberg B, Østergaard MS, Singh RB,
International Primary Care Respiratory Group (IPCRG): Guidelines:
management of asthma. Prim Care Respir J 2006, 15(1):35–47.
4. Stephens MB, Yew KS: Diagnosis of chronic obstructive pulmonary
disease. Am Fam Physician 2008, 78(1):87–92.
5. Lucas AE, Smeenk FW, Smeele IJ, van Schayck CP: Overtreatment with
inhaled corticosteroids and diagnostic problems in primary care
patients, an exploratory study. Fam Pract 2008, 25(2):86–9.
6. Buffels J, Degryse J, Liistro G: Diagnostic certainty, co-morbidity, and
medication in a primary care population with presumed airway
obstruction: the DIDASCO2 study. Prim Care Respir J 2009, 18(1):34–40.
7. Tinetti ME, Bogardus ST, Agostini JV: Potential pitfalls of disease-specific
guidelines for patients with multiple conditions. N Engl J Med 2004,
351(27):2870–4.
8. Yawn BP, Wollan PC: Knowledge and attitudes of family physicians
coming to COPD continuing medical education. Int J Chron Obstruct
Pulmon Dis 2008, 3(2):311–7.
9. Jochmann A, Scherr A, Jochmann DC, Miedinger D, Török SS, Chhajed PN,
Tamm M, Leuppi JD: Impact of adherence to GOLD guidelines on
symptom prevalence, lung function decline and exacerbation rate in a
Swiss COPD cohort. Swiss Med Wkly 2012; 142:w13567. doi:10.4414/
smw.2012.13567.
Bertella et al. Multidisciplinary Respiratory Medicine 2013, 8:24 Page 7 of 7
http://www.mrmjournal.com/content/8/1/2410. Cazzola M, Bettoncelli G, Sessa E, Cricelli C: Primary care of the patient
with chronic obstructive pulmonary disease in Italy. Respir Med 2009,
103:582–8.
11. Corrado A, Rossi A: How far is real life from COPD therapy guidelines? an
Italian observational study. Respir Med 2012, 106(7):989–97.
12. Bourbeau J, Collet JP, Schwartzman K, Ducruet T, Nault D, Bradley C:
Economic benefits of self-management education in COPD. Chest 2006,
130(6):1704–11.
13. World Health Organization: Manual of the international statistical
classification of diseases, injuries and causes of death, ed 9 revised (ICD-9).
Geneva: World Health Organization; 1977.
14. World Health Organization Collaborating Centre for Drug Statistics
Methodology: Guidelines for ATC classification and DDD assignment 2010.
Oslo; 2009.
15. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupré A, Bégin R, Renzi P,
Nault D, Borycki E, Schwartzman K, Singh R, Collet JP, Chronic Obstructive
Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche
en Santé du Québec: Reduction of hospital utilization in patients with
chronic obstructive pulmonary disease: a disease-specific self-
management intervention. Arch Intern Med 2003, 163(5):585–91.
16. National Clinical Guideline Centre for Acute and Chronic Conditions: Chronic
obstructive pulmonary disease. Management of chronic obstructive pulmonary
disease in adults in primary and secondary care. London (UK): National
Institute for Health and Clinical Excellence (NICE); 2010:61. Clinical guideline;
no. 101) see also http://www.guidelines.gov/content.aspx?
id=23801&search=copd.
17. Seaman J, Leonard AC, Panos RJ: Health care utilization history, GOLD
guidelines, and respiratory medication prescriptions in patients with
COPD. Int J COPD 2010, 5:89e97.
18. Bourbeau J, Sebaldt RJ, Day A, Bouchard J, Kaplan A, Hernandez P, Rouleau
M, Petrie A, Foster G, Thabane L, Haddon J, Scalera A: Practice patterns in
the management of chronic obstructive pulmonary disease in primary
practice: the CAGE study. Can Respir J 2008, 15(1):13–9.
19. Ulrik CS, Hansen EF, Jensen MS, Rasmussen FV, Dollerup J, Hansen G,
Andersen KK, KVASIMODO II study group: Management of COPD in
general practice in denmark-participating in an educational program
substantially improves adherence to guidelines. Int J Chron Obstruct
Pulmon Dis 2010, 5:73–9.
20. Soler N, Ballester E, Martín A, Gobartt E, Miravitlles M, Torres A: Changes in
management of chronic obstructive pulmonary disease (COPD) in
primary care: EMMEPOC study. Respir Med 2010, 104(1):67–75.
21. Yawn BP, Enright PL, Lemanske RF Jr, Israel E, Pace W, Wollan P, Boushey H:
Spirometry can be done in family physicians’ offices and alters clinical
decisions in management of asthma and COPD. Chest 2007, 132(4):1162.
22. Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L: Effect of
primary-care spirometry on the diagnosis and management of COPD.
Eur Respir J 2006, 28(5):945–5.
23. Scalvini S, Tridico C, Glisenti F, Giordano A, Pirini S, Peduzzi P, Auxilia F: The
SUMMA project: a feasibility study on telemedicine in selected Italian
areas. Telemed J E Health 2009, 15(3):261–9.
24. Bonavia M, Averame G, Canonica W, Cricelli C, Fogliani V, Grassi C, Moretti
AM, Ferri P, Rossi A, Paggiaro PL: Feasibility and validation of
telespirometry in general practice: the Italian “alliance” study. Respir Med
2009, 103(11):1732–7.
doi:10.1186/2049-6958-8-24
Cite this article as: Bertella et al.: COPD management in primary care: is
an educational plan for GPs useful?. Multidisciplinary Respiratory Medicine
2013 8:24. Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
